These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19665641)

  • 1. 3-monthly azithromycin administration for trachoma.
    Malhotra-Kumar S; Coenen S; Klugman KP; Goossens H
    Lancet; 2009 Aug; 374(9688):449; author reply 449-50. PubMed ID: 19665641
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.
    Batt SL; Charalambous BM; Solomon AW; Knirsch C; Massae PA; Safari S; Sam NE; Everett D; Mabey DC; Gillespie SH
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2765-9. PubMed ID: 12936971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.
    O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE
    Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ocular antibiotics induce bacterial resistance at extraocular sites.
    Gaynor BD; Chidambaram JD; Cevallos V; Miao Y; Miller K; Jha HC; Bhatta RC; Chaudhary JS; Osaki Holm S; Whitcher JP; Holbrook KA; Fry AM; Lietman TM
    Br J Ophthalmol; 2005 Sep; 89(9):1097-9. PubMed ID: 16113356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass azithromycin distribution and emerging resistance: taking a minimum harms approach.
    Malhotra-Kumar S; Goossens H
    Clin Infect Dis; 2013 Jun; 56(11):1527-9. PubMed ID: 23487372
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.
    Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD
    Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.
    Gaynor BD; Holbrook KA; Whitcher JP; Holm SO; Jha HC; Chaudhary JS; Bhatta RC; Lietman T
    Br J Ophthalmol; 2003 Feb; 87(2):147-8. PubMed ID: 12543738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin].
    Lisby JG; Brasholt M; Teglbjoerg LL
    Ugeskr Laeger; 2002 May; 164(20):2629. PubMed ID: 12043408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
    Haug S; Lakew T; Habtemariam G; Alemayehu W; Cevallos V; Zhou Z; House J; Ray K; Porco T; Rutar T; Keenan J; Lietman TM; Gaynor BD
    Clin Infect Dis; 2010 Sep; 51(5):571-4. PubMed ID: 20649409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma.
    Basilion EV; Kilima PM; Mecaskey JW
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):6-12. PubMed ID: 15550255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misleading titles cause confusion.
    Taylor HR
    Arch Ophthalmol; 2009 Feb; 127(2):225; author reply 225. PubMed ID: 19204251
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between erythromycin and azithromycin resistance in Streptococcus pneumoniae.
    Wasas AD; Huebner RE; Hockman M; Klugman KP
    S Afr Med J; 2003 Apr; 93(4):283. PubMed ID: 12806721
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcal vaccine--direct and indirect ("herd") effects.
    Musher DM
    N Engl J Med; 2006 Apr; 354(14):1522-4. PubMed ID: 16598050
    [No Abstract]   [Full Text] [Related]  

  • 18. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global elimination of trachoma: how frequently should we administer mass chemotherapy?
    Lietman T; Porco T; Dawson C; Blower S
    Nat Med; 1999 May; 5(5):572-6. PubMed ID: 10229236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.